Article

AAO initiates EyeSmart program to educate about eye disease

San Francisco-The risk of age-related eye disease is one that Americans do not realize according to a national health survey conducted by the American Academy of Ophthalmology (AAO). The AAO is issuing a new public initiative called EyeSmart to educate Americans about the risks they face.

San Francisco-The risk of age-related eye disease is one that Americans do not realize according to a national health survey conducted by the American Academy of Ophthalmology (AAO). The AAO is issuing a new public initiative called EyeSmart to educate Americans about the risks they face.

Only 11% of Americans find themselves at high risk for eye disease according to a survey conducted by Greenberg Quinlan Rosner Research. Americans over the age of 65 are the most at risk, however, only 10% believe they are at risk.

Age-related eye diseases such as cataract, diabetic retinopathy, glaucoma, and age-related macular degeneration are expected to increase from 28 million to 43 million by the year 2020, according to the organization. Americans are more concerned with weight gain and joint and back pain then they are with vision loss.

The AAO recommends that adults with no signs or risk factors for eye disease get a baseline eye disease screening at age 40. People with a family history of eye disease, diabetes, or high blood pressure should consult their physician to determine how often an examination is needed.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.